Posts Tagged ‘pharmaceuticals’
The BPM approach to Aggregate Spend compliance
Posted by: Ethan Smith in: ● April 27, 2010
In today’s Life Sciences world everything is becoming increasingly more difficult – all of the “easy” drugs have been discovered, the human genome has been mapped and parts even patented (albeit with much dispute), the blockbuster model has crumbled, cost pressures are intensifying and regulatory scrutiny is at an all time high. The cries for [...]
